Noronic Pharma

Ahmedabad, India Founded: 2015 • Age: 11 yrs
Manufactures and exports high-quality pharmaceutical products.

About Noronic Pharma

Noronic Pharma is a Healthcare company based in Ahmedabad (India) founded in 2015. It manufactures and exports high-quality pharmaceutical products. It operates on a B2B model. The company has 8 employees. Its Indian entity Noronic Pharmaceutical Private Limited reported revenue of β‚Ή46.65 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Export. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Noronic Pharma manufactures and exports high-quality pharmaceutical products through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and export. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Ahmedabad, India
  • Employees 8
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website noronicpharma.com
  • Legal Name Noronic Pharmaceutical Private Limited
  • Date of Incorporation 04 Jul, 2016
  • Jurisdiction Kadi, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹46.65 Cr

    FY 2025 · +65% YoY

  • Net Profit
    ₹96.2 Lakh

    FY 2025 · 2% margin

  • EBITDA
    ₹2.67 Cr

    FY 2025 · 6% margin

  • Employee Count
    8

Board of directors of Noronic Pharmaceutical Private Limited (Noronic Pharma)

Noronic Pharmaceutical Private Limited is the primary company behind Noronic Pharma. The board of Noronic Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Nikulkumar Bharatbhai Patel, appointed in 2016. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Nikulkumar Bharatbhai Patel
DIN 07552153
Director04 Jul 201610 yrs 3 moNoronic Pharmaceutical Private Limited
Maulikkumar Rameshbhai Patel
DIN 09134045
Director05 Apr 20215 yrs 6 moNoronic Pharmaceutical Private Limited

Financials of Noronic Pharma

Figures of Noronic Pharmaceutical Private Limited, the primary company behind Noronic Pharma, for FY 2025. Revenue was ₹46.65 Cr (+65% year on year). Net profit was ₹96.2 Lakh (2% margin). EBITDA was ₹2.67 Cr (6% margin). Revenue has grown at a compounded annual rate of +74% over three years and +34% over five years.

  • ₹46.65 CrRevenue · FY 2025 · +65% YoY
  • ₹96.2 LakhNet profit · 2% margin
  • ₹2.67 CrEBITDA · 6% margin
  • ₹10 LakhPaid-up capital
  • 8Employees (provident fund records)
  • +74%Revenue CAGR, 3 years
  • +34%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Noronic Pharmaceutical Private Limited are on its company page.

Premium access

Detailed financial statements for Noronic Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Noronic Pharma

Noronic Pharma has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Noronic Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Noronic Pharma

Noronic Pharma was founded in 2015.

Noronic Pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Noronic Pharma has 8 employees.

The primary company behind Noronic Pharma, Noronic Pharmaceutical Private Limited, reported revenue of β‚Ή46.65 Cr for FY 2025, up 65% year on year.

Noronic Pharma manufactures and exports high-quality pharmaceutical products through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and export. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Noronic Pharma's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Noronic Pharma operates through Noronic Pharmaceutical Private Limited.

The legal entities of Noronic Pharma currently have 2 directors, including Nikulkumar Bharatbhai Patel, Maulikkumar Rameshbhai Patel.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available